nalmefene has been researched along with Cerebral Hemorrhage in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, R; Guo, R; Li, H; Lin, S; Liu, M; You, C; Zheng, J | 1 |
| Deal, DD; Dewitt, DS; Prough, DS; Uchida, T; Vines, SM | 1 |
2 other study(ies) available for nalmefene and Cerebral Hemorrhage
| Article | Year |
|---|---|
Neuroprotection of nalmefene for postoperative patients with spontaneous intracerebral hemorrhage.
Topics: Adult; Aged; Cerebral Hemorrhage; China; Female; Humans; Male; Middle Aged; Naltrexone; Neuroimaging; Neuroprotective Agents; Postoperative Complications; Retrospective Studies; Severity of Illness Index; Stroke; Treatment Outcome | 2015 |
Effects of nalmefene, CG3703, tirilazad, or dopamine on cerebral blood flow, oxygen delivery, and electroencephalographic activity after traumatic brain injury and hemorrhage.
Topics: Animals; Antioxidants; Blood Gas Analysis; Blood Pressure; Brain Injuries; Cats; Cerebral Hemorrhage; Cerebrovascular Circulation; Dopamine; Electroencephalography; Female; Hemoglobins; Male; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Oxygen Consumption; Pregnatrienes; Thyrotropin-Releasing Hormone | 1997 |